Novimmune's New Rheumatoid Arthritis Drug Clears Regulatory Hurdles
November 02, 2015 09:00 ET
|
Novimmune SA
GENEVA, SWITZERLAND--(Marketwired - Nov 2, 2015) - Novimmune SA announced today that it received approvals from the U.S. Food and Drug Administration and the U.K. Medicines and Healthcare products...
Novimmune Announces Presentations at 2015 American College of Rheumatology (ACR) Annual Meeting
November 02, 2015 09:00 ET
|
Novimmune SA
GENEVA, SWITZERLAND--(Marketwired - Nov 2, 2015) - Novimmune, a Swiss biotech company focused on the discovery and development of antibody-based drugs for the targeted treatment of inflammatory...
Novimmune Sponsors Matthew and Andrew Akin Foundation '700 Miles to Hope' Bicycle Ride
September 14, 2015 09:00 ET
|
Novimmune SA
GENEVA, SWITZERLAND--(Marketwired - Sep 14, 2015) - Novimmune, a Swiss biotech company focused on the discovery and development of antibody-based drugs for the targeted treatment of inflammatory...
Novimmune and Baxalta ink international bispecific antibody collaboration
September 02, 2015 06:15 ET
|
Novimmune SA
GENEVA, SWITZERLAND--(Marketwired - Sep 2, 2015) - Novimmune SA announced today that it has signed an international research collaboration agreement with Baxalta Incorporated (Baxalta) to develop...
700 Miles to Hope, Supported by Novimmune, Brings HLH Research Closer to a Cure
September 24, 2014 09:00 ET
|
The Matthew and Andrew Akin Foundation
ST. LOUIS, MO--(Marketwired - Sep 24, 2014) - The Matthew and Andrew Akin Foundation today announced that Novimmune will support its 2014 700 Miles to Hope bike ride as a sponsor. The Swiss biotech...